Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Airsculpt Technologies ( (AIRS) ) has shared an announcement.
On May 12, 2026, AirSculpt Technologies held its 2026 annual meeting in a virtual-only format, with 93.49% of the 70,486,528 eligible Class A common shares represented. Shareholders were asked to vote on the election of three Class II directors and the ratification of the company’s independent auditor for the fiscal year ending December 31, 2026.
Stockholders elected Adam Feinstein, Thomas Aaron, and Kenneth Higgins as Class II directors, each to serve until the 2029 annual meeting of stockholders. They also ratified the selection of Grant Thornton LLP as the independent registered public accounting firm for 2026, and no additional matters were submitted for a vote at the meeting.
The most recent analyst rating on (AIRS) stock is a Hold with a $4.50 price target. To see the full list of analyst forecasts on Airsculpt Technologies stock, see the AIRS Stock Forecast page.
Spark’s Take on AIRS Stock
According to Spark, TipRanks’ AI Analyst, AIRS is a Neutral.
The score is driven primarily by a mixed financial profile: continued losses and pressured margins offset by improved cash flow and reduced leverage. Technically, momentum is positive but looks extended (RSI/Stoch elevated). Valuation is a headwind due to negative earnings and no dividend data. The earnings call adds cautious support via 2026 guidance and turnaround progress, tempered by liquidity, supply, and reporting-control risks.
To see Spark’s full report on AIRS stock, click here.
More about Airsculpt Technologies
AirSculpt Technologies operates in the medical aesthetics industry, focusing on minimally invasive body contouring procedures. The company targets patients seeking cosmetic fat removal and body sculpting services, competing in the broader elective cosmetic surgery and aesthetic medicine market.
Average Trading Volume: 2,784,310
Technical Sentiment Signal: Hold
Current Market Cap: $293.5M
For a thorough assessment of AIRS stock, go to TipRanks’ Stock Analysis page.